hypothyroidism and glp-1 Microdosing for Hashimoto's: Evidence, Risks NHS Guidance – Bolt Pharmacy glp-1 and hypothyroidism Hashimoto's GLP-1:

Rarely, numerous lentigines may develop following an infection or an exanthem and exceptionally they are generalized (generalized lentigines, lentigines profusa)

doi: 10.1038/s41423-022-00925-7 64 LiuSGongHLiPHuJLiYXuRet al

Medications that can enhance the activity of insulin (so-called incretin mimetics) can help to overcome insulin resistance caused by SGAs (and potentially by other psychotropic medications) and essentially lead to weight loss through enhanced fuel efficiency. Metformin, typically dosed up to 1,000 mg twice daily with meals, has increasingly become recognized as a first-line strategy to attenuate weight gain and glycemic dysregulation from SGAs via its ability to reduce insulin resistance

This is to avoid dependence and a build-up of tolerance

doi: 10.1210/jcem.82.5.3943 121 AitmanTJRaffertyBCoyDLynchSSClaytonRN

Slower recovery from illnesses